Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 CAD | -.--% | -2.11% | +17.72% |
04-08 | HLS Therapeutics Inc. Announces Reduce-IT Analysis Results Relating the Effects of VASCEPA | CI |
03-14 | Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.